Clinical Trial: A Long Term Follow-up Study of TScan TCR-T Products

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976736) titled 'A Long Term Follow-up Study of TScan TCR-T Products' on April 18.

Brief Summary: The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.

Study Start Date: Sept., 2025

Study Type: OBSERVATIONAL

Condition: AML ALL MDS

Intervention: OTHER: Observational

Long Term Follow-Up for participants treated with TSC-100 or TSC-101 TCR-T products

Recruitment Status: NOT_YET_RECRUITING

Sponsor: T...